Option Chain

Emergent Biosolutions Inc

EBSNYSE · USD

6.06USD+0.21 (+3.59%)

1015

Emergent Biosolutions Inc (EBS) Option Chain

Emergent Biosolutions Inc trades at $6.06, up 3.59%, with an IV Rank of 51.59%. This is average versus the past year, and the company carries a market cap of $301M in the Drug Manufacturers - Specialty & Generic industry. On the Nov 20, 2026 chain, the at the money $6.00 strike shows calls at $0.10 / $0.50 and puts at $0.35 / $0.55, both carrying about $0.35 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $7.00 calls, at 1 contracts, and the $6.00 puts, at 5, as of Nov 5, 2026.

Tracking the EBS option chain helps you see every strike and expiry on Emergent Biosolutions Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of EBS options activity at a glance. Use our scanner to monitor the EBS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For EBS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where EBS options are being actively traded, and where they are not.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
1.61	0	0	0.67	2.06	0.55	4.90	4.00	-31.62	—	4.00	0.00	4.00	0	0	98.39
20.06	3	0	3.84	1.06	—	4.90	5.00	-14.53	—	0.20	0.00	0.20	1	18	79.94
58.86	45	0	0.24	0.06	0.10	0.50	6.00	+2.56	0.35	0.55	0.00	0.45	5	154	41.14
86.93	258	1	0.10	0.00	0.05	0.15	7.00	+19.66	0.60	1.75	0.94	0.23	0	29	13.07
97.14	298	0	0.25	0.00	—	0.25	8.00	+36.75	0.10	4.90	1.94	0.56	0	20	2.86

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
IV Rank51.59% Moderate
Market cap (M$)301
52 weeks high-58.39%
52 weeks low34.17%
Analyst recommendationBuy
2.33
Target price$10.00
81.52% above the current stock price
Dividend—
Payout ratio0.00%
Earnings date2026-11-02
P/E—
Future P/E5.59
EPS (ttm)-5.10
EPS growth next 5 years0.83%

As of Nov 5, 2026

Browse all Option Chain tickers